Technology
New Oriental Announces Results for the Fourth Fiscal Quarter and the Fiscal Year Ended May 31, 2024
Published
2 years agoon
By
BEIJING, July 31, 2024 /PRNewswire/ — New Oriental Education & Technology Group Inc. (the “Company” or “New Oriental”) (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results for the fourth fiscal quarter and fiscal year ended May 31, 2024.
Financial Highlights for the Fourth Fiscal Quarter Ended May 31, 2024
Total net revenues increased by 32.1% year over year to US$1,136.7 million for the fourth fiscal quarter of 2024.Operating income decreased by 78.1% year over year to US$10.5 million for the fourth fiscal quarter of 2024.Net income attributable to New Oriental decreased by 6.9% year over year to US$27.0 million for the fourth fiscal quarter of 2024.
Key Financial Results
(in thousands US$, except per ADS(1) data)
4Q FY2024
4Q FY2023
% of change
Net revenues
1,136,679
860,571
32.1 %
Operating income
10,527
48,054
-78.1 %
Non-GAAP operating income (2)(3)
36,324
78,592
-53.8 %
Net income attributable to New Oriental
26,972
28,959
-6.9 %
Non-GAAP net income attributable to New Oriental (2)(3)
36,931
62,091
-40.5 %
Net income per ADS attributable to New Oriental – basic
0.16
0.18
-6.9 %
Net income per ADS attributable to New Oriental – diluted
0.16
0.17
-5.8 %
Non-GAAP net income per ADS attributable to New Oriental – basic (2)(3)(4)
0.22
0.38
-40.5 %
Non-GAAP net income per ADS attributable to New Oriental – diluted (2)(3)(4)
0.22
0.37
-40.5 %
(in thousands US$, except per ADS(1) data)
FY2024
FY2023
% of change
Net revenues
4,313,586
2,997,760
43.9 %
Operating income
350,425
190,046
84.4 %
Non-GAAP operating income (2)(3)
472,883
279,834
69.0 %
Net income attributable to New Oriental
309,591
177,341
74.6 %
Non-GAAP net income attributable to New Oriental (2)(3)
381,123
258,909
47.2 %
Net income per ADS attributable to New Oriental – basic
1.87
1.06
77.2 %
Net income per ADS attributable to New Oriental – diluted
1.85
1.03
79.3 %
Non-GAAP net income per ADS attributable to New Oriental – basic (2)(3)(4)
2.30
1.54
49.4 %
Non-GAAP net income per ADS attributable to New Oriental – diluted (2)(3)(4)
2.27
1.51
50.0 %
(1) Each ADS represents ten common shares. The Hong Kong-listed shares are fully fungible with the ADSs listed on
NYSE.
(2) GAAP represents Generally Accepted Accounting Principles in the United States of America.
(3) New Oriental provides net income attributable to New Oriental, operating income and net income per ADS
attributable to New Oriental on a non-GAAP basis that excludes share-based compensation expenses and gain
(loss) from fair value change of investments to provide supplemental information regarding its operating
performance. For more information on these non-GAAP financial measures, please see the section captioned “About
Non-GAAP Financial Measures” and the tables captioned “Reconciliations of Non-GAAP Measures to the Most
Comparable GAAP Measures” set forth at the end of this release.
(4) The Non-GAAP net income per ADS attributable to New Oriental is computed using Non-GAAP net income
attributable to New Oriental and the same number of shares and ADSs used in GAAP basic and diluted EPS
calculation.
Operating Highlights for the Fourth Fiscal Quarter Ended May 31, 2024
The total number of schools and learning centers was 1,025 as of May 31, 2024, an increase of 114 and 277 compared to 911 as of February 29, 2024 and 748 as of May 31, 2023, respectively. The total number of schools was 81 as of May 31, 2024.
Michael Yu, New Oriental’s Executive Chairman, commented, “We are pleased to conclude the final quarter of fiscal year 2024 with a healthy top line growth of 32.1%. Our overseas test preparation and overseas study consulting businesses increased by approximately 17.7% and 17.3% year over year, respectively. In addition, the domestic test preparation business targeting adults and university students recorded a growth of approximately 16.4% year over year. Furthermore, our new educational business initiatives have all sustained strong momentum in this fiscal quarter, with a 50.3% revenue growth year over year. Among these new educational business initiatives, our non-academic tutoring courses were offered in around 60 cities, attracting approximately 875,000 student enrollments in this fiscal quarter. Simultaneously, our intelligent learning system and devices were adopted in around 60 cities, with approximately 188,000 active paid users in this fiscal quarter. On top of the strong growth, it is also encouraging to see the continuous improvement in customer retention rate. We will keep on our effort in enhancing quality of our product offerings and services. We firmly believe in the bright future of these new business initiatives and our strength in capturing the new market opportunity.”
Chenggang Zhou, New Oriental’s Chief Executive Officer, added, “During this fiscal quarter, we accelerated our capacity expansion in some existing cities with greater growth potential and higher facility utilization, thereby increasing profitability. As of the end of this fiscal year, the total number of schools and learning centers increased to 1,025. As our key educational businesses delivered sustainable growth, we continued to allocate resources to our online-merge-offline teaching system and apply new technologies to enhance the quality of our educational and product offerings. Upholding the customer-centric strategy, East Buy Holding Limited (“East Buy”) consistently provides customers with healthy, delicious, and cost-effective products. Since the launch of its first private label product in April 2022, East Buy has developed and launched over 400 SKUs within just two years, expanding its product line from agriculture, food and beverage products to a variety of product categories, among which some of its hot-selling products have achieved excellent performance in the market with strong competitiveness.”
Stephen Zhihui Yang, New Oriental’s Executive President and Chief Financial Officer, commented, “Our GAAP operating margin for the quarter was 0.9% and Non-GAAP operating margin for the quarter was 3.2%. Our investment in accelerated capacity expansion and newly-integrated tourism-related business, as well as additional incentives to management and staff have led to the short-term impact on our operating margin in this quarter. We anticipate the pressure on margins for educational businesses will reduce in the next fiscal year as we continue to improve the utilization of facilities and operating efficiency. We will stick to our commitment on creating sustainable value for our customers and shareholders in the long term.”
Recent Development
On November 21, 2023, as part of the Company’s business line reorganization, the Company’s wholly-owned subsidiary and variable interest entity (the “New Oriental Group Entities”) entered into an agreement with East Buy and its subsidiaries and variable interest entity, pursuant to which the New Oriental Group Entities agreed to acquire East Buy’s online education business at an aggregate consideration of RMB1.5 billion. The consideration was agreed by the parties after arm’s length negotiations, with reference to an independent valuation. The acquisition was completed in this fiscal quarter. Upon completion, the online education business was deconsolidated from East Buy’s consolidated financial statements and is now recorded by the Company under educational services.
Share Repurchase
The Company’s board of directors approved a share repurchase program in July 2022, under which the Company is authorized to repurchase up to US$400 million of the Company’s ADSs or common shares through the next twelve months. The Company’s board of directors further approved to extend the effective time of the share repurchase program to May 31, 2025. As of July 30, 2024, the Company repurchased an aggregate of approximately 7.3 million ADSs for approximately US$296.1 million from the open market.
Financial Results for the Fourth Fiscal Quarter Ended May 31, 2024
Net Revenues
For the fourth fiscal quarter of 2024, New Oriental reported net revenues of US$1,136.7 million, representing a 32.1% increase year over year. The growth was mainly driven by the increase in net revenues from our educational new business initiatives and East Buy private label products and livestreaming e-commerce business.
Operating Costs and Expenses
Operating costs and expenses for the quarter were US$1,126.2 million, representing a 38.6% increase year over year. Non-GAAP operating costs and expenses for the quarter, which exclude share-based compensation expenses, were US$1,100.4 million, representing a 40.7% increase year over year. The increase was primarily due to the cost and expenses related to the substantial growth in East Buy private label products and livestreaming e-commerce business and accelerated capacity expansion for educational businesses.
Cost of revenues increased by 38.5% year over year to US$542.4 million.Selling and marketing expenses increased by 40.9% year over year to US$208.2 million.General and administrative expenses for the quarter increased by 37.5% year over year to US$375.5 million. Non-GAAP general and administrative expenses, which exclude share-based compensation expenses, were US$355.2 million, representing a 42.3% increase year over year.
Total share-based compensation expenses, which were allocated to related operating costs and expenses, decreased by 15.5% to US$25.8 million in the fourth fiscal quarter of 2024.
Operating Income and Operating Margin
Operating income was US$10.5 million, representing a 78.1% decrease year over year. Non-GAAP income from operations for the quarter was US$36.3 million, representing a 53.8% decrease year over year.
Operating margin for the quarter was 0.9%, compared to 5.6% in the same period of the prior fiscal year. Non-GAAP operating margin, which excludes share-based compensation expenses, for the quarter was 3.2%, compared to 9.1% in the same period of the prior fiscal year.
Net Income and Net Income per ADS
Net income attributable to New Oriental for the quarter was US$27.0 million, representing a 6.9% decrease year over year. Basic and diluted net income per ADS attributable to New Oriental were US$0.16 and US$0.16, respectively.
Non-GAAP Net Income and Non-GAAP Net Income per ADS
Non-GAAP net income attributable to New Oriental for the quarter was US$36.9 million, representing a 40.5% decrease year over year. Non-GAAP basic and diluted net income per ADS attributable to New Oriental were US$0.22 and US$0.22, respectively.
Cash Flow
Net operating cash inflow for the fourth fiscal quarter of 2024 was approximately US$376.8 million and capital expenditures for the quarter were US$27.4 million.
Balance Sheet
As of May 31, 2024, New Oriental had cash and cash equivalents of US$1,389.4 million. In addition, the Company had US$1,489.4 million in term deposits and US$2,065.6 million in short-term investment.
New Oriental’s deferred revenue, which represents cash collected upfront from customers and related revenue that will be recognized as the services or goods are delivered, at the end of the fourth quarter of fiscal year 2024 was US$1,780.1 million, an increase of 33.1% as compared to US$1,337.6 million at the end of the fourth quarter of fiscal year 2023.
Financial Results for the Fiscal Year Ended May 31, 2024
For the fiscal year 2024 ended May 31, 2024, New Oriental reported net revenues of $4,313.6 million, representing a 43.9% increase year over year.
Operating income from operations for the fiscal year 2024 was US$350.4 million, representing a 84.4% increase year over year. Non-GAAP operating income for the fiscal year 2024 was US$472.9 million, representing a 69.0% increase year over year.
Operating margin for the fiscal year 2024 was 8.1%, compared to 6.3% for the prior fiscal year. Non-GAAP operating margin, which excludes share-based compensation expenses for the fiscal year 2024, was 11.0%, compared to 9.3% for the prior fiscal year.
Net income attributable to New Oriental for the fiscal year 2024 was US$309.6 million, representing a 74.6% increase year over year. Basic and diluted net income per ADS attributable to New Oriental for the fiscal year 2024 amounted to US$1.87 and US$1.85, respectively.
Non-GAAP net income attributable to New Oriental for the fiscal year 2024 was US$381.1 million, representing a 47.2% increase year over year. Non-GAAP basic and diluted net income per ADS attributable to New Oriental for the fiscal year 2024 amounted to US$2.30 and US$2.27, respectively.
Outlook for the First Quarter of the Fiscal Year 2025
New Oriental expects total net revenues, excluding revenues generated from East Buy private label products and livestreaming business, in the first quarter of the fiscal year 2025 (June 1, 2024 to August 31, 2024) to be in the range of US$1,254.7 million to US$1,283.5 million, representing year over year increase in the range of 31% to 34%.
This forecast reflects New Oriental’s current and preliminary view, which is subject to change.
Conference Call Information
New Oriental’s management will host an earnings conference call at 8 AM on July 31, 2024, U.S. Eastern Time (8 PM on July 31, 2024, Beijing/Hong Kong Time).
Please register in advance of the conference, using the link provided below. Upon registering, you will be provided with participant dial-in numbers, and unique personal PIN.
Conference call registration link: https://register.vevent.com/register/BIc2dde5e6a20144cfb19927a1c9cff6d0. It will automatically direct you to the registration page of “New Oriental FY2024 Q4 Earnings Conference Call” where you may fill in your details for RSVP.
In the 10 minutes prior to the call start time, you may use the conference access information (including dial in number(s) and personal PIN) provided in the confirmation email received at the point of registering.
Joining the conference call via a live webcast:
Additionally, a live and archived webcast of the conference call will be available at http://investor.neworiental.org.
Listening to the conference call replay:
A replay of the conference call may be accessed via the webcast on-demand by registering at https://edge.media-server.com/mmc/p/o6s9tzw6/ first. The replay will be available until July 31, 2025.
About New Oriental
New Oriental is a provider of private educational services in China offering a wide range of educational programs, services and products to a varied student population throughout China. New Oriental’s program, service and product offerings mainly consist of educational services and test preparation courses, private label products and livestreaming e-commerce and other services, overseas study consulting services, and educational materials and distribution. New Oriental is listed on NYSE (NYSE: EDU) and SEHK (9901.SEHK), respectively. New Oriental’s ADSs, each of which represents ten common shares, are listed and traded on the NYSE. The Hong Kong-listed shares are fully fungible with the ADSs listed on NYSE.
For more information about New Oriental, please visit http://www.neworiental.org/english/.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the outlook for the first quarter of fiscal year 2025, quotations from management in this announcement, as well as New Oriental’s strategic and operational plans, contain forward-looking statements. New Oriental may also make written or oral forward-looking statements in its reports filed or furnished to the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about New Oriental’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: our ability to effectively and efficiently manage changes of our existing business and new business; our ability to execute our business strategies; uncertainties in relation to the interpretation and implementation of or proposed changes to, the PRC laws, regulations and policies regarding the private education industry; our ability to attract students without a significant increase in course fees; our ability to maintain and enhance our “New Oriental” brand; our ability to maintain consistent teaching quality throughout our school network, or service quality throughout our brand; our ability to achieve the benefits we expect from recent and future acquisitions; the outcome of ongoing, or any future, litigation or arbitration, including those relating to copyright and other intellectual property rights; competition in the private education sector and livestreaming e-commerce business in China; the continuing efforts of our senior management team and other key personnel, health epidemics and other outbreaks in China; and general economic conditions in China. Further information regarding these and other risks is included in our annual report on Form 20-F and other documents filed with the Securities and Exchange Commission. New Oriental does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and New Oriental undertakes no duty to update such information, except as required under applicable law.
About Non-GAAP Financial Measures
To supplement New Oriental’s consolidated financial results presented in accordance with GAAP, New Oriental uses the following measures defined as non-GAAP financial measures by the SEC: net income excluding share-based compensation expenses and gain (loss) from fair value change of investments, operating income excluding share-based compensation expenses, operating cost and expenses excluding share-based compensation expenses, general and administrative expenses excluding share-based compensation expenses, operating margin excluding share-based compensation expenses, and basic and diluted net income per ADS and per share excluding share-based compensation expenses and gain (loss) from fair value change of investments. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned “Reconciliations of non-GAAP measures to the most comparable GAAP measures” set forth at the end of this release.
New Oriental believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance and liquidity by excluding share-based compensation expenses and gain (loss) from fair value change of investments that may not be indicative of its operating performance from a cash perspective. New Oriental believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning and forecasting future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to New Oriental’s historical performance and liquidity. New Oriental believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making. A limitation of using these non-GAAP measures is that they exclude share-based compensation charge and gain (loss) from fair value change of investments that has been and will continue to be for the foreseeable future a significant recurring expense in our business. Management compensates for these limitations by providing specific information regarding the GAAP amounts excluded from each non-GAAP measure. The accompanying tables have more details on the reconciliations between GAAP financial measures that are most directly comparable to non-GAAP financial measures.
Contacts
For investor and media inquiries, please contact:
Ms. Rita Fong Ms. Sisi Zhao
FTI Consulting New Oriental Education & Technology Group Inc.
Tel: +852 3768 4548 Tel: +86-10-6260-5568
Email: rita.fong@fticonsulting.com Email: zhaosisi@xdf.cn
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
As of May 31
As of May 31
2024
2023
(Unaudited)
(Audited)
USD
USD
ASSETS:
Current assets:
Cash and cash equivalents
1,389,359
1,662,982
Restricted cash, current
177,411
110,892
Term deposits, current
1,320,167
855,784
Short-term investments
2,065,579
1,477,843
Accounts receivable, net
29,689
33,074
Inventory, net
92,806
52,689
Prepaid expenses and other current assets, net
309,464
211,240
Amounts due from related parties, current
4,403
9,383
Total current assets
5,388,878
4,413,887
Restricted cash, non-current
22,334
31,553
Term deposits, non-current
169,203
462,734
Property and equipment, net
507,981
359,760
Land use rights, net
4,450
3,321
Amounts due from related parties, non-current
7,273
1,735
Long-term deposits
38,161
26,492
Intangible assets, net
18,672
25,179
Goodwill, net
103,958
105,514
Long-term investments, net
355,812
399,585
Deferred tax assets, net
72,727
55,933
Right-of-use assets
653,905
439,535
Other non-current assets
188,319
67,230
Total assets
7,531,673
6,392,458
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
105,681
69,764
Accrued expenses and other current liabilities
774,805
569,437
Income taxes payable
139,822
118,049
Amounts due to related parties
551
346
Deferred revenue
1,780,063
1,337,630
Operating lease liability, current
199,933
155,752
Total current liabilities
3,000,855
2,250,978
Deferred tax liabilities
19,407
23,849
Unsecured senior notes
14,403
14,653
Operating lease liabilities, non-current
447,994
288,190
Total long-term liabilities
481,804
326,692
Total liabilities
3,482,659
2,577,670
Equity
New Oriental Education & Technology Group Inc. shareholders’ equity
3,775,934
3,604,348
Non-controlling interests
273,080
210,440
Total equity
4,049,014
3,814,788
Total liabilities and equity
7,531,673
6,392,458
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands except for per share and per ADS amounts)
For the Three Months Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Net revenues
1,136,679
860,571
Operating cost and expenses (note 1)
Cost of revenues
542,398
391,615
Selling and marketing
208,241
147,793
General and administrative
375,513
273,109
Total operating cost and expenses
1,126,152
812,517
Operating income
10,527
48,054
Gain/(Loss) from fair value change of investments
10,412
(7,565)
Other income, net
35,820
31,349
Provision for income taxes
(5,531)
(19,442)
Loss from equity method investments
(22,606)
(12,480)
Net income
28,622
39,916
Add: Net income attributable to non-controlling interests
(1,650)
(10,957)
Net income attributable to New Oriental Education &
Technology Group Inc.’s shareholders
26,972
28,959
Net income per share attributable to New Oriental-Basic
(note 2)
0.02
0.02
Net income per share attributable to New Oriental-Diluted
(note 2)
0.02
0.02
Net income per ADS attributable to New Oriental-Basic
(note 2)
0.16
0.18
Net income per ADS attributable to New Oriental-Diluted
(note 2)
0.16
0.17
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
RECONCILIATIONS OF NON-GAAP MEASURES TO THE MOST COMPARABLE GAAP MEASURES
(In thousands except for per share and per ADS amounts)
For the Three Months Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
General and administrative expenses
375,513
273,109
Less: Share-based compensation expenses in
general and administrative expenses
20,332
23,587
Non-GAAP general and administrative expenses
355,181
249,522
Total operating cost and expenses
1,126,152
812,517
Less: Share-based compensation expenses
25,797
30,538
Non-GAAP operating cost and expenses
1,100,355
781,979
Operating income
10,527
48,054
Add: Share-based compensation expenses
25,797
30,538
Non-GAAP operating income
36,324
78,592
Operating margin
0.9 %
5.6 %
Non-GAAP operating margin
3.2 %
9.1 %
Net income attributable to New Oriental
26,972
28,959
Add: Share-based compensation expenses
20,371
25,567
Less: Gain/(Loss) from fair value change of
investments
10,412
(7,565)
Non-GAAP net income attributable to New Oriental
36,931
62,091
Net income per ADS attributable to New Oriental-
Basic (note 2)
0.16
0.18
Net income per ADS attributable to New Oriental-
Diluted (note 2)
0.16
0.17
Non-GAAP net income per ADS attributable to New
Oriental – Basic (note 2)
0.22
0.38
Non-GAAP net income per ADS attributable to New
Oriental – Diluted (note 2)
0.22
0.37
Weighted average shares used in calculating basic
net income per ADS (note 2)
1,653,165,343
1,653,059,954
Weighted average shares used in calculating
diluted net income per ADS (note 2)
1,671,292,756
1,668,721,317
Non-GAAP net income per share – basic
0.02
0.04
Non-GAAP net income per share – diluted
0.02
0.04
Notes:
Note 1: Share-based compensation expenses (in thousands) are included in the operating cost and expenses as follows:
For the Three Months Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Cost of revenues
990
2,743
Selling and marketing
4,475
4,208
General and administrative
20,332
23,587
Total
25,797
30,538
Note 2: Each ADS represents ten common shares.
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
For the Three Months Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Net cash provided by operating activities
376,835
421,609
Net cash (used in)/provided by investing activities
(864,010)
64,939
Net cash used in financing activities
(109,230)
(76,522)
Effect of exchange rate changes
(3,565)
(35,600)
Net change in cash, cash equivalents and restricted cash
(599,970)
374,426
Cash, cash equivalents and restricted cash at beginning of
period
2,189,074
1,431,001
Cash, cash equivalents and restricted cash at end of
period
1,589,104
1,805,427
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands except for per share and per ADS amounts)
For the Year Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Net revenues
4,313,586
2,997,760
Operating cost and expenses (note 1):
Cost of revenues
2,050,960
1,409,438
Selling and marketing
660,586
444,693
General and administrative
1,251,615
953,583
Total operating cost and expenses
3,963,161
2,807,714
Operating income
350,425
190,046
Gain/(Loss) from fair value change of investments
19,025
(860)
Other income, net
124,391
119,345
Provision for income taxes
(109,690)
(66,066)
Loss from equity method investments
(58,933)
(7,102)
Net income
325,218
235,363
Add: Net income attributable to non-controlling interests
(15,627)
(58,022)
Net income attributable to New Oriental Education &
Technology Group Inc.’s shareholders
309,591
177,341
Net income per share attributable to New Oriental-Basic
(note 2)
0.19
0.11
Net income per share attributable to New Oriental-
Diluted (note 2)
0.18
0.10
Net income per ADS attributable to New Oriental-Basic
(note 2)
1.87
1.06
Net income per ADS attributable to New Oriental-
Diluted (note 2)
1.85
1.03
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
RECONCILIATION OF NON-GAAP MEASURES TO THE MOST COMPARABLE GAAP MEASURES
(In thousands except for per share and per ADS amounts)
For the Year Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
General and administrative expenses
1,251,615
953,583
Less: Share-based compensation expenses in general
and administrative expenses
76,439
81,289
Non-GAAP general and administrative expenses
1,175,176
872,294
Total operating cost and expenses
3,963,161
2,807,714
Less: Share-based compensation expenses
122,458
89,788
Non-GAAP operating cost and expenses
3,840,703
2,717,926
Operating income
350,425
190,046
Add: Share-based compensation expenses
122,458
89,788
Non-GAAP operating income
472,883
279,834
Operating margin
8.1 %
6.3 %
Non-GAAP operating margin
11.0 %
9.3 %
Net income attributable to New Oriental
309,591
177,341
Add: Share-based compensation expenses
90,557
80,708
Less: Gain/(Loss) from fair value change of
investments
19,025
(860)
Non-GAAP net income attributable to New Oriental
381,123
258,909
Net income per ADS attributable to New Oriental-
Basic (note 2)
1.87
1.06
Net income per ADS attributable to New Oriental-
Diluted (note 2)
1.85
1.03
Non-GAAP net income per ADS attributable to New
Oriental – Basic (note 2)
2.30
1.54
Non-GAAP net income per ADS attributable to New
Oriental – Diluted (note 2)
2.27
1.51
Weighted average shares used in calculating basic net
income per ADS (note 2)
1,653,597,432
1,678,264,547
Weighted average shares used in calculating diluted
net income per ADS (note 2)
1,669,499,952
1,685,631,987
Non-GAAP net income per share – basic
0.23
0.15
Non-GAAP net income per share – diluted
0.23
0.15
Notes:
Note 1: Share-based compensation expenses (in thousands) are included in the operating costs and expenses as follows:
For the Year Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Cost of revenues
19,967
2,749
Selling and marketing
26,052
5,750
General and administrative
76,439
81,289
Total
122,458
89,788
Note 2: Each ADS represents ten common shares.
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
For the Year Ended May 31
2024
2023
(Unaudited)
(Unaudited)
USD
USD
Net cash provided by operating activities
1,122,643
971,008
Net cash used in investing activities
(1,153,922)
(37,411)
Net cash used in financing activities
(160,438)
(246,867)
Effect of exchange rate changes
(24,606)
(75,830)
Net change in cash, cash equivalents and restricted cash
(216,323)
610,900
Cash, cash equivalents and restricted cash at beginning of
period
1,805,427
1,194,527
Cash, cash equivalents and restricted cash at end of
period
1,589,104
1,805,427
View original content:https://www.prnewswire.com/news-releases/new-oriental-announces-results-for-the-fourth-fiscal-quarter-and-the-fiscal-year-ended-may-31-2024-302210902.html
SOURCE New Oriental Education and Technology Group Inc.
You may like
Technology
Kidney Patients Back Bipartisan Bill to Expand Disability Employment
Published
12 minutes agoon
October 23, 2026By
U.S. Representatives Hoyer and Sessions Lead AbilityOne Modernization Bill
Kidney Disease and Jobs are Focus of National Disability Employment Month
WASHINGTON, Oct. 23, 2026 /PRNewswire/ — The American Association of Kidney Patients (AAKP), the nation’s oldest and largest independent kidney patient advocacy organization, today announced plans to accelerate national grassroots patient advocacy in support of bipartisan legislation that will modernize the federal AbilityOne program. The American Procurement Improvement Act (APIA), H.R. 10443, is championed by U.S. Representatives Pete Sessions (R-TX) and Steny Hoyer (D-MD). AAKP defines kidney disease as both an American healthcare and workforce issue and fights to expand career opportunities and job protections for all Americans impacted by kidney disease, disabilities, and chronic diseases.
The AbilityOne program creates private sector employment opportunities for over 41,000 Americans with severe vision and other disabilities, including nearly 3,000 American Veterans. In FY 2025, the program generated nearly 48 million direct labor hours, an 8 percent increase and a significant measure of disability employment growth, with workers working and working more hours. AbilityOne delivered more than $4.7 billion in products and services to the Federal government in FY 2025 and drew discouraged workers into the U.S. labor force while supporting greater workforce participation, increasing economic independence, and self-sufficiency. The AbilityOne mission taps the underutilized workforce of people with significant disabilities to deliver high-quality, mission-essential products and services to federal agencies, including the U.S. Department of Defense and the U.S. Department of Homeland Security.
The APIA legislation removes outdated statutory barriers to hiring, retention, advancement, and movement into careers of choice, including emerging fields and new lines of business. It also modernizes federal procurement by aligning AbilityOne with contemporary procurement practices and streamlines procurement processes so the program can respond faster to emerging federal agency priorities. The APIA legislation protects taxpayer interests, strengthens program accountability and stewardship by preserving oversight, transparency, and worker protections while modernizing AbilityOne Commission authorities. The legislation is seen as an opportunity to improve federal procurement and strengthen the federal government’s domestic supplier base.
Over 36 million Americans live with kidney disease, over 600,000 are on dialysis, and nearly 100,000 are awaiting a kidney transplant. Further, interrelated cardiovascular, kidney, and metabolic diseases have impacted more than 25% of the adult population and are a leading cause of death. More broadly, the American Heart Association estimates that 90% of U.S. adults, or about 240 million people, have some degree of interconnected cardiovascular, kidney, or metabolic health conditions. For kidney patients dependent upon status-quo, in-center hemodialysis, burdensome thrice-weekly dialysis sessions force many patients, against their own choosing, into unemployment, disability, and dependency. AAKP believes dialysis-related unemployment, and the associated costs borne by families and taxpayers, is one of the media’s least-reported stories in legacy kidney care. AAKP’s policy agenda focuses on transplant readiness, more opportunities for organ transplants, more flexible, patient-centered home dialysis solutions, and stronger job protections for both kidney patients and living organ donors.
AAKP President Edward V. Hickey, III, a chronic kidney disease patient, stated, “AAKP strongly endorses the American Procurement Improvement Act (APIA) and expresses our deepest gratitude to Representatives Steny Hoyer and Peter Sessions for their bipartisan leadership and commitment to Americans managing disabilities and their efforts to secure meaningful employment opportunities with solid wages. People impacted by disability and chronic diseases face tremendous hurdles to continued employment and return to the workforce – especially America’s proud Veterans. This legislation reflects consensus language among stakeholders, including advocates, employers, and organized labor, and sends a very positive message, amid national economic concerns, that the voices and needs of disabled Americans and their families are heard and not forgotten by the U.S. Congress. We encourage Congress to step up and pass this legislation before the close of the year.” Hickey is a U.S. Marine Corps Veteran, a former senior congressional aide, and has served in appointed roles in two presidential administrations, including the U.S. Department of Commerce (DOC) and the U.S. Office of Personnel Management (OPM). At OPM, he was heavily involved in policy issues related to federal Veterans preference in civil service hiring and expanded federal job opportunities. He currently serves on the American Board of Internal Medicine’s (ABIM) Nephrology Specialty Board and as the Chair of the AAKP Veterans Health Initiative, the largest kidney health outreach program outside of the U.S. Department of Veterans Affairs.
October is National Disability Employment Month, and AAKP and its allies remind elected and appointed government leaders to address health and employment concerns that impact patients, families, and communities. Through multiple partnerships, AAKP leads the kidney community in providing kidney patients and transplant recipients, including Veterans, access to virtual job fairs and employment skills training opportunities. AAKP is currently sponsoring virtual job fairs, in partnership with CareerEco, on January 13, 2027, and May 18, 2027, that will service Veterans and military families. AAKP’s past collaborations have included webinars with Idealist and virtual disability and Veteran hiring fairs with Bender Consulting.
AAKP Vice President and Chair of Policy and Global Affairs Paul T. Conway, a 49-year kidney patient and 29-year transplant recipient, stated, “The AbilityOne program has supported private sector employment for people managing disabilities and chronic diseases for nearly ninety years and reflects the exceptional American values of self-reliance and independence. Representatives Steny Hoyer and Pete Sessions have consistently shown respect for the creativity, talents, and skills of disabled citizens and have dedicated their public careers to expanding job opportunities in the workforce and across the federal supply chain. The American Procurement Improvement Act increases accountability for taxpayer funds and will result in more well-paying jobs for Americans whose desire and capacity to work and contribute are underappreciated.” Conway is a former Chief of Staff for both the U.S. Department of Labor and the U.S. Office of Personnel Management and a former Deputy Secretary for Health and Human Resources for the Commonwealth of Virginia. He has overseen multiple federal and state disability employment, workforce training, and health service programs throughout his public career. He is the past Chair of the U.S. Food and Drug Administration’s Patient Engagement Advisory Committee (PEAC) and serves on the Observational Study Monitoring Board of the Kidney Precision Medicine Program (KPMP) administered by the National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases (NIH/NIDDK).
To advance the APIA, AAKP is working with former U.S. Representative Tony Coelho, Chair of the Partnership to Improve Patient Care as well as the Alliance for Expanding America’s Workforce. Along with AAKP, APIA is endorsed by over 60 national patient and disability organizations, labor unions and employers including the American Association of People with Disabilities, SEIU, Bender Consulting, National Council of SourceAmerica Employers, CEO Commission for Disability Employment, the Arc of the United States, National Organization on Disability, National Down Syndrome Society, National Disability Rights Network, National Federation of the Blind, Melwood Inc., WORK Inc., ORC Industries, Employment Source, Opportunity Center, Inc., PARC, ACHIEVE Human Services, Inc., Human Technologies, InspiriTec, PORTCO Inc, PRIDE Industries, Phoenix, Pueblo Diversified Industries, and the Association of People Supporting EmploymentFirst (APSE).
AAKP, alongside a broad and diverse coalition of patient organizations, transplant experts, and Congressional allies, is also working to secure passage of the Living Donor Protection Act (LDPA), S. 1552/H.R. 4582 and H.R. 4583, in 2026. The bipartisan bill protects living organ donors from job and insurance discrimination based solely on their decision to donate a kidney to save another life, barriers cited most often by potential organ donors. The bipartisan legislation is led by Senator Tom Cotton (R-AK) and Senator Kirsten Gillibrand (D-NY). It was voted out of the Senate HELP Committee on February 26, 2026, with full bipartisan support, the endorsement of AAKP, the larger kidney community, and the American Council of Life Insurance (ACLI).
In 2018, with bipartisan support from Congress and the Trump Administration, AAKP and transplant professionals worked with the U.S. Department of Labor’s (DOL) legal team and the DOL Wage and Hour Division to have DOL issue Family and Medical Leave Act (FMLA) protections for living organ donors, based on the original intent of the FMLA’s Congressional co-sponsors (click here to read the letter and click here to watch the video). Congressional passage of the LDPA in 2026 will codify the DOL’s 2018 FMLA job protections and prohibit insurers from discriminating against living donors. Increased living organ donation, improved transplant readiness among kidney patients, and greater opportunities for transplantation have been national goals for decades and were reinforced in 2019 through the Executive Order on Advancing American Kidney Health.
Follow AAKP on social media at @kidneypatient on Facebook, @kidneypatients on X, and @kidneypatients on Instagram, and visit https://aakp.org/ for more information. AAKP patient advocates advance bipartisan kidney policy including: passage of the bipartisan law modernizing the Organ Procurement and Transplantation Network (OPTN) (2023); lifetime transplant drug coverage for kidney patients (2020); the historic Executive Order on Advancing American Kidney Health signed by President Donald Trump (2019); job protections for living organ donors under the Family Medical Leave Act (FMLA) via the U.S. Department of Labor (2018); and Congressional approval of HIV positive organ transplants for HIV positive patients (2013).
MEDIA CONTACT:
Brendan LaCivita
National and Medical Media Specialist
blacivita@aakp.org
(813) 906-7740
View original content to download multimedia:https://www.prnewswire.com/news-releases/kidney-patients-back-bipartisan-bill-to-expand-disability-employment-302918393.html
SOURCE American Association of Kidney Patients
Technology
BioVid Launches Mimetics™, AI Research Audiences Built on How Physicians Reason and Decide
Published
12 minutes agoon
October 23, 2026By
Modeling physician response patterns and behavior, showing an 80–90% match with real physicians on content, reasoning, and emotion.
BRISTOL, Pa., Oct. 23, 2026 /PRNewswire/ — BioVid, a life science consultancy, today announced the launch of BioVid Mimetics™, a research platform that gives pharmaceutical teams mimetics: synthetic physician audiences modeled on how those audiences reason and decide. Its respondent models are grounded in BioVid’s proprietary MindSet Modeling™ program, large-scale, multi-specialty surveys of practicing physicians that measure the mindsets shaping how they process information, make judgments, and decide. The models are aligned with secondary data on clinical practice, moving beyond generic AI role-play to model the decision logic behind treatment choices.
Prescribing data shows what physicians choose, not why. Pharma teams now face more of those “why” questions than research budgets and timelines can absorb. BioVid Mimetics™ applies the social and behavioral science of clinical judgment to model how physicians interpret evidence, weigh benefit against risk, and decide when they know enough to act.
The name comes from pharmacology, where a mimetic earns trust by doing the work of the original molecule. Every BioVid mimetic is tested against that standard, bringing the firm’s long-standing commitment to science-based research to a new method.
“At BioVid, we’ve always believed that better commercial decisions start with a deeper understanding of human behavior,” said Peggy Hirtle, CEO of BioVid. “Our goal was never simply faster or cheaper respondents. It was to reflect how physicians actually reason, with the same scientific rigor clients already trust from BioVid. Mimetics is a new way to put human understanding to work, never a replacement for it.”
“A synthetic respondent can sound right and still reason wrong. The real test is whether it reasons the way the audience does,” said Marco Barcella, Executive Director, Product & Technology at BioVid. “Where the decision warrants, we run the same study with a human cohort and a mimetic cohort and compare the findings, the reasoning, and the mental and emotional responses directly. Clients see where mimetic findings hold and where human research should lead.”
In BioVid’s validation work to date, mimetic and human cohorts have shown an 80% to 90% match on content, reasoning, and emotion across thousands of parallel tests.
BioVid Mimetics™ is available off the shelf or tailored with a client’s own primary research. It supports message and concept testing, positioning, drivers and barriers, segmentation, and opportunity assessment, and includes:
Mimetic Respondents: Mimetic or hybrid studies, with mimetic fieldwork complete in one to two weeks after receipt of required inputs, followed by a full report and readout from BioVid’s research team.
Mimetic Segments App: Segments that client teams question directly, share materials with, and return to between research waves.
Client Customization: Models tailored with a client’s own research, segment profiles, and CRM data, exclusive to that client and firewalled from all others.
To learn more, visit www.biovid.com/mimetics.
About BioVid
BioVid is a life science consultancy applying behavioral science and AI to commercial and market access strategy. Its offerings include the CIAIRA™ AI platform, Tumor Worlds™, and BioVid Mimetics™. BioVid is a recognized leader in new product demand estimation, commercial communication optimization, and customer and patient segmentation research.
Visit www.biovid.com.
Media Contact:
Sal Zerilli, PhD, Executive Director, Knowledge and Innovation, BioVid
szerilli@biovid.com | 267.201.4008
View original content to download multimedia:https://www.prnewswire.com/news-releases/biovid-launches-mimetics-ai-research-audiences-built-on-how-physicians-reason-and-decide-302918401.html
SOURCE BioVid
Technology
Egan-Jones Finds Steady CLO Credit Metrics as Interest Rates Turn Higher
Published
12 minutes agoon
October 23, 2026By
NEW YORK, Oct. 23, 2026 /PRNewswire/ — Egan-Jones released its monthly report on the collateralized loan obligation (CLO) market, finding that credit metrics across the deals it rates held steady even as interest rates and high-yield spreads moved higher in September. For investors, the publication sets these steadier portfolio measures against a tighter rate backdrop.
Among Egan-Jones’ measures, the weighted average rating score, a gauge of the default risk in a deal’s underlying loans where a lower score indicates stronger credit, has improved over the past year. The share of assets rated CCC+ or lower, the weakest tier of loan ratings, has been stable to slightly lower, with a median of 6.1%. As of September 2026, Egan-Jones rated 1,568 CLO deals.
The steadier metrics come as financing conditions shift. The 5-year Treasury yield rose 60 basis points to 5.09%, its highest close of 2026, and on September 16 the Federal Reserve raised rates by 25 basis points, its first increase since 2023. High-yield spreads widened to 312 basis points from their late-August low, while new CLO issuance totaled 91 deals ($38.2 billion), down 12.5% by count from a year earlier.
Higher rates cut both ways for CLOs, according to the analysis: coupons on the underlying loans reset upward, but so do the interest burdens of the borrowers. Egan-Jones points to rising loss severity on distressed exchanges and other selective defaults, and identifies software loans, pressured by concerns over disruption from artificial intelligence, as the weakest sector in CLO portfolios.
Egan-Jones also compares its ratings with those of other agencies across 20 deals, ranking the tranches where views differ most. On that comparison, Egan-Jones currently tends to take a more positive view of CLO credit quality than other credit rating agencies. A full sample rating report on MP CLO VIII, whose largest industry exposure is High Tech Industries at 15.9%, is included.
Taken together, the findings describe a market in which issuance has eased and borrowing costs are rising, while the credit profile of Egan-Jones-rated portfolios remains stable. Watching where pressures such as software exposure and loss severity are building may help investors assess CLO risk as the rate cycle turns.
About Egan-Jones Ratings
Egan-Jones, an NRSRO founded in 1995, offers timely and accurate credit ratings and proxy services.
Media Contact:
sales@egan-jones.com
+1 212 425 0460
View original content to download multimedia:https://www.prnewswire.com/news-releases/egan-jones-finds-steady-clo-credit-metrics-as-interest-rates-turn-higher-302918341.html
SOURCE Egan-Jones Ratings Co.
Kidney Patients Back Bipartisan Bill to Expand Disability Employment
BioVid Launches Mimetics™, AI Research Audiences Built on How Physicians Reason and Decide
Egan-Jones Finds Steady CLO Credit Metrics as Interest Rates Turn Higher
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology4 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Technology5 days agoHISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
-
Coin Market4 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology5 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Technology5 days agoTrend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
-
Technology5 days agoSALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
-
Technology4 days agoTreasuries Rallied as Tech Slid, and the Crowded Bet Against Bonds Felt It
